Metabolic dysfunction–associated steatotic liver disease (MASLD): Integrating metabolic and hepatic management into pharmacy practice

Key Points

• This research aims to highlight the importance of optimizing care for patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
• Identifying comorbidities associated with MASLD.
• Collaborating with healthcare professionals for effective patient management.
• Ensuring access to necessary medications for patients.
• Improved patient outcomes through early recognition of MASLD.
• Enhanced safety in medication management for patients with MASLD.